Browse All

Current Filters

CLEAR FILTER x

TITLE

Author Institution:

Safety and Efficacy of Continuous Subcutaneous Levodopa/Carbidopa Infusion for Parkinson’s disease: Three-Year Data from the Open-Label BeyoND study

Author:Ellenbogen, Aaron   Adar, Liat   Salin, Laurence   Case, Ryan   Yardeni, Tamar   Espay, Alberto   

Session Name:PL4: Contemporary Clinical Issues Plenary Session  

Topic:Movement Disorders  

Program Number:PL4.003  

Author Institution:Michigan Institute for Neurological Disorders, Farmington Hills, MI  NeuroDerm, Rehovot, Israel  NeuroDerm, West Chester, PA  University of Cincinnati, Cincinnati, OH  

Relative bioavailability of levodopa administered as a subcutaneous infusion with ND0612 versus oral immediate-release levodopa/carbidopa tablets

Author:Adar, Liat   Vostokova, Natalia   

Session Name:P2: Movement Disorders: Clinical Trials in Parkinson's Disease 2  

Topic:Movement Disorders  

Program Number:P2.004  

Author Institution:NeuroDerm, Rehovot, Israel